| 000 | 01068 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516142645.0 | ||
| 264 | 0 | _c20131219 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1879-0844 | ||
| 024 | 7 |
_a10.1093/eurjhf/hft055 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTao, Hui | |
| 245 | 0 | 0 |
_aGalectin-3, new potential therapeutic target for cardiac remodelling. _h[electronic resource] |
| 260 |
_bEuropean journal of heart failure _cJun 2013 |
||
| 300 |
_a709 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGalectin 3 _xblood |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 700 | 1 | _aShi, Kai-Hu | |
| 700 | 1 | _aYang, Jing-Jing | |
| 773 | 0 |
_tEuropean journal of heart failure _gvol. 15 _gno. 6 _gp. 709 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurjhf/hft055 _zAvailable from publisher's website |
| 999 |
_c22622957 _d22622957 |
||